IRVINE, Calif.--(BUSINESS WIRE)--June 21, 2006--Cobalis Corp. (OTC BB: CLSC - News), a pharmaceutical development company focused on the treatment of allergy and other atopic conditions, announced today that its Patent No. 1128835, titled "Cyanocobalamin Treatment in Allergic Disease," has been published by the European Patent Office in the European Patent Bulletin 06/25. With its publication today, the patent is now in effect and protects the method of treatment underlying Cobalis' PreHistin® anti-allergy medication.
